UnitedHealth Group Re-Establishes Full Year Outlook and Reports Second Quarter 2025 Results

UnitedHealth Group Re-Establishes Full Year Outlook and Reports Second Quarter 2025 Results

UnitedHealth Group (NYSE: UNH) reported second quarter 2025 results and updated its 2025 outlook. “UnitedHealth Group has embarked on a rigorous path back to being a high-performing company fully serving the health needs of individuals and society broadly,” said Stephen Hemsley, chief executive officer of UnitedHealth Group. “As we strengthen operating disciplines, positioning us for…

Read More
UnitedHealth Group (UNH) Sees a More Significant Dip Than Broader Market: Some Facts to Know

UnitedHealth Group (UNH) Sees a More Significant Dip Than Broader Market: Some Facts to Know

UnitedHealth Group (UNH) closed the most recent trading day at $282.65, moving -1.88% from the previous trading session. The stock’s performance was behind the S&P 500’s daily loss of 0.01%. Meanwhile, the Dow experienced a drop of 0.32%, and the technology-dominated Nasdaq saw an increase of 0.05%. Shares of the largest U.S. health insurer witnessed…

Read More
Health insurers move to streamline prior authorization process, promising quicker care

Health insurers move to streamline prior authorization process, promising quicker care

UnitedHealthcare, Kaiser Permanente and other major U.S. health insurers say they want to make it faster and easier for patients to obtain care. Health Insurance Plans (AHIP), a trade association that represents the health insurance industry, announced Monday that some of its biggest members are taking steps to streamline “prior authorization” — industry jargon for…

Read More
UnitedHealth CEO Andrew Witty unexpectedly steps down as insurer suspends financial outlook

UnitedHealth CEO Andrew Witty unexpectedly steps down as insurer suspends financial outlook

UnitedHealth CEO Andrew Witty is resigning from his position for personal reasons, the insurance company announced on Tuesday.  UnitedHealth also said that it would suspend its 2025 financial outlook due to higher-than-expected medical costs. The move to withhold guidance followed its first quarterly earnings miss in more than a decade. The company did not immediately…

Read More